Feasibility of proposed single-nucleotide polymorphisms as predictive markers for targeted regimens in metastatic colorectal cancer

J C Kim; Y J Ha; S A Roh; E Y Choi; Y S Yoon; K P Kim; Y S Hong; T W Kim; D H Cho; S Y Kim; Y S Kim

首页> 外文期刊>British Journal of Cancer >Feasibility of proposed single-nucleotide polymorphisms as predictive markers for targeted regimens in metastatic colorectal cancer

【24h】

Feasibility of proposed single-nucleotide polymorphisms as predictive markers for targeted regimens in metastatic colorectal cancer

机译：拟议的单核苷酸多态性作为转移性结直肠癌靶向治疗方案的预测指标的可行性

获取原文

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Background:Surrogate biomarkers for metastatic colorectal cancer (mCRC) are urgently needed to achieve the best outcomes for targeted therapy.

机译：背景：迫切需要用于转移性结直肠癌（mCRC）的替代生物标志物，以实现靶向治疗的最佳结果。

著录项

来源
《British Journal of Cancer》 |2013年第9期|共8页
作者
J C Kim; Y J Ha; S A Roh; E Y Choi; Y S Yoon; K P Kim; Y S Hong; T W Kim; D H Cho; S Y Kim; Y S Kim;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Feasibility of novel PPP1R15A and proposed ANXA11 single nucleotide polymorphisms as predictive markers for bevacizumab regimen in metastatic colorectal cancer [J] . Roh Seon Ae, Park In Ja, Yoon Yong Sik, Journal of Cancer Research and Clinical Oncology . 2016,第8期

机译：新型PPP1R15A和拟议的ANXA11单核苷酸多态性作为贝伐单抗方案在转移性结直肠癌中的预测标记的可行性
2. Novel chemosensitive single-nucleotide polymorphism markers to targeted regimens in metastatic colorectal cancer. [J] . Kim JC, Kim SY, Cho DH, Clinical cancer research: an official journal of the American Association for Cancer Research . 2011,第5期

机译：新型化学敏感性单核苷酸多态性标志物靶向转移结肠直肠癌的治疗方案。
3. UGT1A1*6, UGT1A7*3 and UGT1A9*1b polymorphisms are predictive markers for severe toxicity in patients with metastatic gastrointestinal cancer treated with irinotecan-based regimens [J] . Cui Chengxu, Shu Chang, Cao Dandan, Oncology letters . 2016,第5aPta2期

机译：UGT1A1 * 6，UGT1A7 * 3和UGT1A9 * 1b多态性是基于伊立替康治疗的转移性胃肠道癌患者严重毒性的预测指标
4. Predicting cancer susceptibility from single-nucleotide polymorphism data [C] . Michael Waddell, David Page, John Shaughnessy Proceedings of the 5th international workshop on Bioinformatics . 2005

机译：从单核苷酸多态性数据预测癌症易感性
5. Single-nucleotide polymorphisms in 17beta-hydroxysteroid dehydrogenase type III and prostate cancer risk. [D] . Kim, Eugene. 2003

机译：17β-羟类固醇脱氢酶III型中的单核苷酸多态性和前列腺癌的风险。
6. Feasibility of proposed single-nucleotide polymorphisms as predictive markers for targeted regimens in metastatic colorectal cancer [O] . J C Kim, Y J Ha, S A Roh, 2013

机译：拟议的单核苷酸多态性作为转移性结直肠癌靶向治疗方案的预测指标的可行性
7. Clinical significance of UGT1A1 gene polymorphisms on irinotecan-based regimens as the treatment in metastatic colorectal cancer [O] . Zhehai Wang, Minmin Li, Jun Guo, 2014

机译：UGT1A1基因多态性对基于伊替康的方案作为转移结直肠癌治疗的临床意义

Feasibility of proposed single-nucleotide polymorphisms as predictive markers for targeted regimens in metastatic colorectal cancer

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅